Notice Number: NOT-NS-13-035
Update: The following update relating to this announcement has been issued:
- September 26, 2013 - See Notice NOT-NS-13-042. Notice of the Extension of the Response Date.
Key Dates
Release Date: July 18, 2013
Response Due Date: September 30, 2013 (Extended to October 31, 2013 per NOT-NS-13-042)
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), is the primary federal agency responsible for funding research on Parkinson's Disease (PD). On January 6-7, 2014, the NINDS will sponsor a public conference to assess critical needs and related opportunities for advancing PD research and treatment.
The purpose of this time-sensitive Request for Information (RFI) is to seek comprehensive perspective on the most significant challenges and highest priorities for basic, translational and clinical research on PD.
This RFI is intended to gather information relevant to conference planning and should not be construed as a funding opportunity.
Information Requested
This RFI is intended to solicit broad community perspective on scientific opportunities and outstanding needs for research and treatment of PD.
The NINDS invites input from stakeholders including but not limited to researchers in academia and industry, healthcare professionals, patient advocates and advocacy organizations, scientific and professional organizations, Federal agencies and other interested members of the public. Organizations are encouraged to submit a single response that reflects the views of the organization as a whole. Responses will be used to inform the 2014 NINDS PD conference.
The NINDS is interested in basic, translational and clinical PD research, as well as interdisciplinary approaches that span these areas. Please provide perspectives on the following topics:
- New and/or ongoing challenges and opportunities for PD research and treatment breakthroughs.
- The highest individual priority for PD in each of the following: basic, translational and clinical research; as well as the impact that accomplishment of stated priority areas would have on laboratory-based science, clinical trials, patient well-being and public health.
- Specific elements needed to address these basic, translational and clinical priorities and to remove any related obstacles. Examples of such elements might include but are not limited to: enhanced tools, technologies, other research resources; novel combinations of research team expertise and collaboration; bioinformatics resources; infrastructure.
How to Submit a Response
To ensure consideration, responses must be received by September 30, 2013 and must be submitted electronically using the web-based format at www.ninds.nih.gov/funding/RFI-PD.htm. The web format will provide confirmation of response submission, but respondents will not receive individualized feedback.
Responses to this RFI are voluntary and may be submitted anonymously. Please do not include any personally identifiable or other information that you do not wish to make public. Proprietary, classified, confidential or sensitive information should not be included in your response. Comments submitted will be compiled for discussion at the upcoming January 2014 conference and may appear in related reports. Any personal identifiers (names, e-mail addresses, etc.) will be removed when responses are compiled.
This RFI is for informational and planning purposes only and should not be construed as a solicitation or as an obligation on the part of the United States (US) Government, the NIH or the NINDS to provide support for any ideas submitted in response to it. Please note that the US Government, NIH and NINDS will not pay for the preparation of any information submitted, or for its use of that information.
Inquiries
Please direct all inquiries to:
Beth-Anne Sieber, PhD
Program Director, Neurodegeneration
National Institute of Neurological Disorders and Stroke
Email: sieberb@ninds.nih.gov
and Human Services (HHS)
